[HTML][HTML] Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy

SKA Súss, CO Mesa Jr, GA Carvalho… - … of Endocrinology and …, 2018 - SciELO Brasil
Objective To retrospectively evaluate the outcomes of patients with low and intermediate risk
thyroid carcinoma treated with total thyroidectomy (TT) and who did not undergo radioiodine …

Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy

SKA Súss, CO Mesa Junior, GA Carvalho… - … of Endocrinology and …, 2018 - inis.iaea.org
[en] Objective: To retrospectively evaluate the outcomes of patients with low and
intermediate risk thyroid carcinoma treated with total thyroidectomy (TT) and who did not …

[PDF][PDF] Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy

SKA Súss, CO Mesa Jr, GA de Carvalho… - 129 Improving care of …, 1915 - endocrino.org.br
Objective: To retrospectively evaluate the outcomes of patients with low and intermediate
risk thyroid carcinoma treated with total thyroidectomy (TT) and who did not undergo …

[HTML][HTML] Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy

SKA Súss, CO Mesa Jr, GA de Carvalho… - … of Endocrinology and …, 2018 - ncbi.nlm.nih.gov
Objective To retrospectively evaluate the outcomes of patients with low and intermediate risk
thyroid carcinoma treated with total thyroidectomy (TT) and who did not undergo radioiodine …

[PDF][PDF] Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy

SKA Súss, CO Mesa Jr, GA de Carvalho, FY Miasaki… - academia.edu
Objective: To retrospectively evaluate the outcomes of patients with low and intermediate
risk thyroid carcinoma treated with total thyroidectomy (TT) and who did not undergo …

Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy

SKA Súss, CO Mesa Jr, GA Carvalho, FY Miasaki… - sidalc.net
Objective To retrospectively evaluate the outcomes of patients with low and intermediate risk
thyroid carcinoma treated with total thyroidectomy (TT) and who did not undergo radioiodine …

Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy

SKA Súss, CO Mesa Jr, GA Carvalho… - Arch. endocrinol …, 2018 - pesquisa.bvsalud.org
Objective To retrospectively evaluate the outcomes of patients with low and intermediate risk
thyroid carcinoma treated with total thyroidectomy (TT) and who did not undergo radioiodine …

Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy.

SKA Súss, CO Mesa Jr, GA Carvalho… - … of Endocrinology and …, 2018 - europepmc.org
Objective To retrospectively evaluate the outcomes of patients with low and intermediate risk
thyroid carcinoma treated with total thyroidectomy (TT) and who did not undergo radioiodine …

[PDF][PDF] Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy

SKA Súss, CO Mesa Jr, GA de Carvalho, FY Miasaki… - scholar.archive.org
Objective: To retrospectively evaluate the outcomes of patients with low and intermediate
risk thyroid carcinoma treated with total thyroidectomy (TT) and who did not undergo …

[PDF][PDF] Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy

SKA Súss, CO Mesa Jr, GA de Carvalho, FY Miasaki… - scienceopen.com
Objective: To retrospectively evaluate the outcomes of patients with low and intermediate
risk thyroid carcinoma treated with total thyroidectomy (TT) and who did not undergo …